Nektar Therapeutics (NKTR)
42.26
+0.36
(+0.85%)
USD |
NASDAQ |
Dec 31, 16:00
42.26
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Free Cash Flow: -190.35M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Insmed, Inc. | -906.14M |
| Lyell Immunopharma, Inc. | -165.54M |
| Owlet, Inc. | -7.686M |
| Amgen, Inc. | 11.54B |
| Rigel Pharmaceuticals, Inc. | 68.14M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -48.76M |
| Cash from Investing (Quarterly) | -94.87M |
| Cash from Financing (Quarterly) | 141.68M |
| Free Cash Flow Per Share (Quarterly) | -2.580 |
| Free Cash Flow to Equity (Quarterly) | -39.22M |
| Free Cash Flow to Firm (Quarterly) | -42.83M |
| Free Cash Flow Yield | -6.98% |